MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$24,409K
EPS
-$0.5
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
18,474 23,668* 19,270 17,724
General and administrative
8,791 5,791* 4,656 4,081
Total operating expenses
27,265 29,458 23,926 21,805
Loss from operations
-27,265 -29,458* -23,926 -21,805
Interest and other income, net
3,748 4,031* 2,308 2,394
Net loss
-23,517 -25,427* -21,618 -19,411
Unrealized loss on marketable securities
-892 94* 143 -42
Reclassification of net gains included in net loss
-14* --
Total other comprehensive loss
-892 80* 143 -42
Total comprehensive loss
-24,409 -25,348 -21,475 -19,453
Basic EPS
-0.5 -0.605 -0.63 -0.58
Diluted EPS
-0.5 -0.605 -0.63 -0.58
Basic Average Shares
46,576,204 41,873,294 34,198,597 33,446,385
Diluted Average Shares
46,576,204 41,873,294 34,198,597 33,446,385
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$24,409K Net loss-$23,517K Total othercomprehensive loss-$892K Interest and otherincome, net$3,748K Loss from operations-$27,265K Unrealized loss onmarketable securities-$892K Total operatingexpenses$27,265K Research and development$18,474K General andadministrative$8,791K

MBX Biosciences, Inc. (MBX)

MBX Biosciences, Inc. (MBX)